Prostata-MRT

Was passiert mit einer Prostata in der Pathologie?

Prostatitis ist der Name, dass

Der Radiologe. Das Prostatakarzinom ist in Deutschland die häufigste Krebserkrankung des Mannes, wobei ein deutlicher Unterschied zwischen Inzidenz und Mortalität Prostata-MRT. Die Detektion des Prostatakarzinoms basiert auf klinischer und laborchemischer Untersuchung prostataspezifisches-Antigen[PSA]-Wert sowie der transrektalen Prostata-MRT mit randomisierter Biopsie.

Die multiparametrische MR-Tomographie kann zur Detektion des Prostatakarzinoms, insbesondere bei negativer Biopsie vor Prostata-MRT erneuten Biopsie wertvolle diagnostische Informationen liefern. Zudem wird zunehmend die Prostata-MRT in der Diagnostik eingesetzt, wodurch die Detektionsrate des Prostatakarzinoms deutlich gesteigert werden kann. Prostate cancer is the most common form Prostata-MRT cancer in men in Germany; however, there is a distinct difference between incidence and mortality.

Prostata-MRT detection of prostate cancer is based on clinical and laboratory testing using serum prostate-specific antigen PSA levels and transrectal Prostata-MRT with randomized biopsy. Multiparametric MR imaging of the prostate Prostata-MRT provide valuable diagnostic information for detection of prostate cancer, especially after negative results of a biopsy prior to Prostata-MRT biopsy.

In addition the use of MR ultrasound Prostata-MRT biopsy Prostata-MRT gained in diagnostic importance Prostata-MRT has increased the prostate cancer detection rate. The prostate imaging reporting Prostata-MRT data system PI-RADS classification has standardized the reporting of prostate MRI which has positively influenced the acceptance by urologists. Skip to main content. Advertisement Hide. Authors Authors and affiliations P.

Asbach M. Haas B. Leitthema First Online: 29 October Klinisches Problem Das Prostatakarzinom ist in Deutschland die häufigste Krebserkrankung Prostata-MRT Mannes, wobei ein deutlicher Unterschied zwischen Inzidenz und Mortalität besteht.

Therapeutische Standardverfahren Die Detektion des Prostatakarzinoms basiert auf klinischer und laborchemischer Untersuchung prostataspezifisches-Antigen[PSA]-Wert sowie der transrektalen Ultraschalluntersuchung mit randomisierter Biopsie. Diagnostik Die multiparametrische MR-Tomographie kann Prostata-MRT Detektion des Prostatakarzinoms, insbesondere bei negativer Biopsie vor einer erneuten Biopsie wertvolle diagnostische Informationen liefern.

Leistungsfähigkeit Zudem wird zunehmend die MRT-Ultraschall-Fusionsbiopsie in der Prostata-MRT eingesetzt, wodurch die Detektionsrate des Prostatakarzinoms deutlich gesteigert werden kann. MR imaging of the Prostata-MRT. Clinical issue Prostate cancer is the most common form Prostata-MRT cancer in men in Germany; however, there is a distinct difference between incidence and mortality.

Standard treatment The detection of prostate cancer is based on clinical and laboratory testing using serum prostate-specific antigen PSA levels and transrectal ultrasound with randomized biopsy. Diagnostic work-up Multiparametric MR imaging of the Prostata-MRT can provide valuable diagnostic information for detection of prostate cancer, especially after negative results of Prostata-MRT biopsy prior to repeat biopsy.

Performance In addition the use of MR ultrasound fusion-guided biopsy has gained in diagnostic importance and has increased the prostate cancer detection rate. Achievements and practical recommendations The prostate imaging reporting and data system PI-RADS classification has standardized the reporting of prostate MRI which has positively influenced the acceptance Prostata-MRT urologists. This is a Prostata-MRT of subscription content, log in to check access. Einhaltung ethischer Richtlinien Interessenkonflikt P.

Asbach, M. Haas und B. Prostata-MRT geben an, dass kein Interessenkonflikt besteht. Baur AD, Maxeiner A, Franiel T et al Evaluation of the prostate imaging reporting and data system for the Prostata-MRT of prostate cancer by the results of targeted biopsy of the prostate. Zugegriffen: Juli Google Scholar. Franiel T, Hamm B, Hricak H Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer. Hamoen EH, de Rooij M, Witjes JA Use of the prostate imaging reporting and data system pi-rads for prostate cancer detection with multiparametric magnetic Prostata-MRT imaging: a diagnostic meta-analysis.

Medved M, Sammet S, Prostata-MRT A, Oto A MR Prostata-MRT of Prostata-MRT prostate and adjacent Prostata-MRT structures before, during, and after ejaculation: qualitative and quantitative evaluation. Muller BG, Shih JH, Sankineni S et al Prostate cancer: Prostata-MRT agreement and accuracy Prostata-MRT the revised prostate imaging reporting and data system at multiparametric MR imaging.

Epub ahead of print. Prostate cancer: diagnosis and treatment. Nowak J, Malzahn U, Baur AD et al The value of ADC, T2 signal intensity, and a combination of both parameters to assess gleason score and primary gleason grades in patients with known prostate cancer.

Acta Radiol Epub ahead of print. Pokorny MR, de Rooij M, Duncan E et al Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance MR imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.

Schouten MG, Hoeks CM, Bomers JG et al Location of prostate cancers determined by multiparametric and MRI-guided biopsy Prostata-MRT patients with elevated prostate-specific antigen level and at least one negative transrectal ultrasound-guided biopsy. Asbach 1 Email author M. Haas 1 B. Hamm 1 1. Personalised recommendations. Cite article How to cite? ENW EndNote. Buy options.